eCite Digital Repository

Patterns and correlates of prescribed and non-prescribed pregabalin use among a sample of people who inject drugs in Australia

Citation

Sutherland, R and Dietze, PM and Gisev, N and Bruno, R and Campbell, G and Memedovic, S and Peacock, A, Patterns and correlates of prescribed and non-prescribed pregabalin use among a sample of people who inject drugs in Australia, Drug and Alcohol Review, 39, (5) pp. 568-574. ISSN 0959-5236 (2020) [Refereed Article]


Preview
PDF
Pending copyright assessment - Request a copy
194Kb
  

DOI: doi:10.1111/dar.13083

Abstract

Introduction and aims: Pregabalin is a gamma-aminobutyric acid analogue registered and subsidised for the treatment of neuropathic pain in Australia. Despite pre-clinical evidence of low abuse potential, there are increasing reports of extramedical use and overdose deaths involving pregabalin. This study aimed to describe patterns of pregabalin use among an Australian sample of people who inject drugs (PWID) and identify sociodemographic, substance use and mental/physical health correlates of prescribed and non-prescribed use.

Design and methods: Data were obtained from the 2018 Illicit Drug Reporting System, comprising a cross-sectional sample of 905 PWID recruited from Australian capital cities. Multinomial logistic regression was used to identify correlates of past 6-month prescribed and non-prescribed pregabalin use.

Results: One-quarter (25%) of participants reported any past 6-month pregabalin use, with 10% reporting prescribed use and 15% non-prescribed use. Past 6-month use of prescribed benzodiazepines and non-prescribed pharmaceutical opioids were associated with both prescribed and non-prescribed pregabalin use compared to no recent pregabalin use. Pain/discomfort on the day of interview was significantly associated with prescribed pregabalin use. Recent use of non-prescribed benzodiazepines and illicit stimulants and past year non-fatal overdose were significantly associated with non-prescribed pregabalin use (compared to no recent pregabalin use).

Discussion and conclusions: Pregabalin use was relatively common among an Australian sample of PWID. Benzodiazepine and pharmaceutical opioid use were positively correlated with both prescribed and non-prescribed pregabalin use, suggesting that education campaigns regarding the risks of harm associated with concomitant use of these substances are warranted (targeting both health professionals and consumers).

Item Details

Item Type:Refereed Article
Keywords:pregabalin misuse, gabapentinoid, injecting; post-marketing product surveillance, pregabalin, prescription drug misuse
Research Division:Psychology
Research Group:Clinical and health psychology
Research Field:Health psychology
Objective Division:Health
Objective Group:Public health (excl. specific population health)
Objective Field:Substance abuse
UTAS Author:Bruno, R (Associate Professor Raimondo Bruno)
ID Code:142491
Year Published:2020
Deposited By:Psychology
Deposited On:2021-01-19
Last Modified:2021-01-20
Downloads:0

Repository Staff Only: item control page